Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.13.11.17 extracted from

  • Laurent, C.; Fabiani, B.; Do, C.; Tchernonog, E.; Cartron, G.; Gravelle, P.; Amara, N.; Malot, S.; Palisoc, M.M.; Copie-Bergman, C.; Glehen, A.T.; Copin, M.C.; Brousset, P.; Pittaluga, S.; Jaffe, E.S.; Coppo, P.
    Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma a clinical and pathological study in 82 patients (2016), Haematologica, 101, 976-984 .
    View publication on PubMedView publication on EuropePMC
Search for more literature for 1.13.11.17

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
plasmablastic lymphoma cell with or without Epstein-Barr virus infection Homo sapiens
-

Synonyms

Synonyms Comment Organism
IDO
-
 Homo sapiens

Expression

Organism Comment Expression
Homo sapiens increased enzyme expression via expression of CD163 antigen in plasmablastic lymphoma, a rare and aggressive diffuse large B-cell lymphoma commonly associated with Epstein-Barr virus co-infection that most often occurs in the context of human immunodeficiency virus infection up

General Information

General Information Comment Organism
physiological function increased enzyme expression in plasmablastic lymphoma, a rare and aggressive diffuse large B-cell lymphoma commonly associated with Epstein-Barr virus co-infection that most often occurs in the context of human immunodeficiency virus infection. The enzyme acts as immunosuppressive molecule and is involved in the tumor immune escape mechanism Homo sapiens